Alain Romero

Five-Year Outcomes of Patients Enrolled in the REVEAL Registry

Harrison W. Farber, Dave P. Miller, Abby Poms et al. · CHEST Journal · 2015 · 520 citations · Full text

Medicine, Cardiology, Cardiothoracic Surgery +9

Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): a phase 2, randomised, double-blind, placebo-controlled trial

Rajiv Agarwal, Patrick Rossignol, Alain Romero et al. · The Lancet · 2019 · 362 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients

R. Ally, Dirk Schürmann, Wolfgang Kreisel et al. · Clinical Infectious Diseases · 2001 · 333 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Safety and Pharmacokinetics of Oral Voriconazole in Patients at Risk of Fungal Infection: A Dose Escalation Study

Hillard M. Lazarus, Jeffrey L. Blumer, Saul Yanovich et al. · The Journal of Clinical Pharmacology · 2002 · 169 citations

Pharmacy, Pharmacokinetics, Pharmacology +16

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

Alain Romero, P. Le Pogamp, Lars‐Göran Nilsson et al. · Clinical Pharmacology & Therapeutics · 2002 · 169 citations

Pharmacy, Pharmacokinetics, Pharmacology +16